Low medial prefrontal dopaminergic activity in autistic children [4]

Lancet

Volumn 350, Issue 9078, 1997, Pages 638-

  Ernst, M ^b   Zametkin, A J ^a   Matochik, J A ^a   Pascualvaca, D ^a   Cohen, R M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR BLOCKING AGENT; FLUORINE 18; HOMOVANILLIC ACID;

ADOLESCENT; ASPERGER SYNDROME; ATTENTION; AUTISM; BLOOD LEVEL; CAUDATE NUCLEUS; CLINICAL ARTICLE; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; LETTER; MALE; MESENCEPHALON; MOTOR ACTIVITY; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; SCHOOL CHILD; SOCIAL BEHAVIOR; SUBSTANTIA NIGRA; URINE LEVEL; VENTRAL TEGMENTUM;

EID: 0342601394     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63326-0     Document Type: Article

References (5)

1. Anderson GM. Studies on the neurochemistry of autism. In: Bauman ML, Kemper TL, eds. The neurobiology of autism. Johns Hopkins University Press, 1994: 227-42.
2. Happe F, Ehlers S, Fletcher P, et al. Theory of mind in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport 1996; 8: 197-201.
3. Ernst M, Zametkin AJ, Matochik JA, et al. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 1996; 334: 1568-604.
4. Goldman-Rakic PS. Regional and cellular fractionation of working memory. Proc Natl Acad Sci 1996; 9: 13473-80.
5. Waterhouse L, Fein D, Modahl C. Neurofunctional mechanisms in autism. Psychol Rev 1996; 103: 457-89.